BIOLIGH was IPO since 2011 and is currently trading in the SHENZHEN STOCK EXCHANGE. Founded in 1993, BIOLIGHT is an internationally established leading provider in medical devices, medical consumables and healthcare solutions. At BIOLIGHT, we look beyond the technology to the experience of dedicated healthcare professionals and find inspirations in the needs of our customers. That is why BIOLIGHT has continued to be considered as a leading innovator in the areas of patient monitoring and emergency responds, Hemodialysis renal care, and digital health homecare solutions.
Biolight, with headquarter in Zhuhai China, has a firm global RND, Marketing, Sales and Service presents. Biolight has established 8 researches and manufacturing plants, 12 subsidiaries, and oversea sales branches covering sales and services in Asia, Africa, Europe, North America, and Latin America expanding over 135 countries and counting.
Firmly committed to our mission: “Pushing the boundary for the better health of mankind”. BIOLIGHT has consistently invested more than 10% of our annual revenues into researches and designed. In 1994 BIOLIGHT brought to market Chinas very first modular multi-parameters patient monitor. In 2000 BIOLIGHT introduced Chinas first electronic digital colposcope. 2004 BIOLIGHT became Chinas only National Patient Monitoring Industry Base involved in facilitation, education, regulation of patient monitoring medical devices on an industry level at a national scale. These are just a fraction of the milestones in our continued pursue of engineering and innovation excellence. To better continue our success and further improve our efficacy in engineering and designs, BIOLIGHT invested heavily in world class laboratories and personnel including 5 specialties GMP laboratories and 8 special technical engineering and testing facilities.
Quality is weaved into every aspect of BIOLIGHTs business. With our mandate: “Efficiency is Money, Quality is Life” in mind BIOLIGHT strives for engineering and manufacturing excellence and building consumer confidents worldwide. In 1996, BIOLIGHT was one of the first companies in China to receive TUV ISO9001/ISO13485 quality system certification. In 2002, BIOLIGHT became the first medical devices company to receive CMD product certification. And since then, BIOLIGHT had acquired CE mark certificate in Electronic Medical Devices, Hemodialysis equipment, medical consumables, and homecare medical products. Later in 2006， BIOLIGHT obtained FDA 510（K）Clearance for products in the field of patient monitoring, emergency respond, surgical monitoring and homecare devices.
BIOLIGHT established 7 high-techs manufacturing campus across China, located in Zhuhai, Tianjin, Liaoning, Chongqing, Changzhou, and Nanchang, with a combine area of 1,898,000 sqm conveniently and efficiently deliver quality products across the country and across the globe. Every aspect of the manufacturing process is controlled through a set of intelligent quality measures. Every product that is comes out of our facilities is put forth a strict complete quality control system to ensure maximum satisfactory and traceability.
BIOLIGHT maintains many long term relationships with top universities, global health organizations, health and social responsibility organizations actively involves in educations, humanitarian mission, and patient care social projects. Fulfilling corporate social responsibility is one of our core missions at BIOLIGHT. As an integral part of global economic ecosystem, BIOLIGHT has made constant effort to contribute to public welfare in China and across, focusing largely in: access to education, access to technology, public health, and sustaining communities. BIOLIGHT will continue to maximize the impact of our corporate responsibility programs by leveraging our unique company resource in biomedical engineering and digital health creating a platform to better focusing on generating values for our society.